Atypical Meningioma
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of the Inflammatory Microenvironment in Atypical Meningiomas (NCT04761653) | Central Hospital, Nancy, France | 2021-01-01 |
| Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms (NCT04541082) | Jazz Pharmaceuticals | 2020-10-26 |
| Oncological Care for Patients With Meningioma (NCT02973256) | University Hospital, Montpellier | 2019-01-01 |
| A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma (NCT03016091) | Rabin Medical Center | 2018-01-01 |
| Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma (NCT02847559) | Northwestern University | 2016-08-01 |
Track Atypical Meningioma automatically
Every clearance here is in the API, with alerts when new ones post.